Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | McElrath: Innate to Adaptive Immunity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2013-02-21 |
| Study Made Public: | 2015-05-12 |
Title
Mixed HIV-1 Envelope Protein Vaccination Yields Superior Antibody Binding Compared to Clonal or Sequential Delivery in Rabbits
Description
CAVD 411 is a preclinical rabbit study to evaluate and compare the anti-viral antibody response of 3 combinations of Clade C HIV envelope trimeric gp140 proteins in a protein/adjuvant vaccine regimen.
Sign in to see full information about this study and to download study data.
Products
PEI Env gp140 CN54 trimeric Env gp140 590c Env gp140 823c Env gp140 756c Env gp140 CN54/590c/756c/823cIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.